Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
38.69
+1.70 (4.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.40
-0.29 (-0.75%)
After-hours: Jun 26, 2026, 7:18 PM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,722,799
Profits / Employee
$2,093,287
Market Cap
715.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Allogene Therapeutics | 152 |
| Inventiva | 77 |
| Aclaris Therapeutics | 73 |
| CytomX Therapeutics | 69 |
| SpyGlass Pharma | 68 |
| Oculis Holding AG | 60 |
| Candel Therapeutics | 55 |
| Climb Bio | 29 |
RIGL News
- 11 days ago - Rigel closes license agreement for Veppanu - TheFly
- 11 days ago - Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) - PRNewsWire
- 11 days ago - Rigel Pharmaceuticals Slides: Corporate presentation - Filings
- 24 days ago - Rigel Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Rigel to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 5 weeks ago - Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress - PRNewsWire
- 5 weeks ago - Rigel Pharmaceuticals Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference - PRNewsWire